CARISMA THERAPEUTICS INC (CARM)
Institutional ownership reported to the SEC as of Q2 2026, across 14 quarters.
1
Reporting holders
$4
Reported value
0.0%
Held as options
-2
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Union Bancaire Privee, UBP SA | $4 | 785 | 0.00% | 7q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $4 | 785 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 3 | $47.9K | 1,474,225 | 1 | 0 | 0 | 0.0% |
| Q4 2025 | 7 | $67.0K | 1,565,031 | 2 | 1 | 0 | 0.0% |
| Q3 2025 | 31 | $836.8K | 3,054,213 | 1 | 3 | 4 | 0.0% |
| Q2 2025 | 36 | $1.6M | 3,982,639 | 5 | 4 | 7 | 0.0% |
| Q1 2025 | 37 | $1.7M | 5,575,824 | 3 | 6 | 5 | 0.0% |
| Q4 2024 | 39 | $2.3M | 5,568,520 | 7 | 5 | 6 | 0.0% |
| Q3 2024 | 36 | $3.9M | 3,953,834 | 2 | 8 | 12 | 0.0% |
| Q2 2024 | 49 | $7.4M | 4,851,522 | 19 | 5 | 16 | 0.0% |
| Q1 2024 | 46 | $16.1M | 7,108,154 | 7 | 11 | 16 | 0.0% |
| Q4 2023 | 46 | $24.3M | 7,571,756 | 2 | 17 | 7 | 8.5% |
| Q3 2023 | 53 | $33.7M | 7,207,471 | 5 | 13 | 17 | 9.6% |
| Q2 2023 | 50 | $71.1M | 7,294,127 | 22 | 14 | 6 | 10.0% |
| Q1 2023 | 32 | $14.4M | 3,288,588 | 34 | 0 | 0 | 29.3% |